Contraindications Contraindications for this combination are the individual contraindications of each compound: GHK-Cu should be avoided if you have: Wilson's disease or other copper metabolism disorders Known allergy to copper or copper peptides Semaglutide should be avoided if you have: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 Active or recent pancreatitis Pregnancy or breastfeeding Monitoring Recommendations For patients using GHK-Cu alongside semaglutide, we recommend: Standard semaglutide monitoring (metabolic panel, HbA1c, lipids at baseline and periodically) Copper and ceruloplasmin levels at baseline if there's any concern about copper metabolism Skin assessment at each follow-up to evaluate tissue response General nutritional assessment to ensure adequate micronutrient intake Monitoring and lab work Frequently Asked Questions Can GHK-Cu cause copper toxicity when used with semaglutide

Dehydration & Electrolytes Rapid rehydration after heat, travel or illness Learn more Hangover Recovery Fluids, anti-nausea & B-vitamins for the morning after Learn more Immune & Cold/Flu Support Vitamin C, zinc & fluids to help you fight back Learn more Low Energy & Fatigue A B-complex boost to beat the midweek wall Learn more Migraines & Headaches Targeted relief for headache and migraine days Learn more Nausea & Stomach Upset Settle nausea and rehydrate gently Learn more Stress & Burnout Magnesium & calming nutrients to help you reset Learn more Muscle Recovery Bounce back after training or a big event Learn more Beauty & Skin Glutathione & antioxidants for a healthy glow Learn more Myers' Cocktail The classic all-around vitamin & mineral reset Learn more NAD+ Therapy Energy, focus & cellular support Learn more Jet Lag & Travel Recovery Rehydrate and reset after a long flight Learn more Serving Seal Beach and nearby
Theranostics 8 , 14941510 (2018)
However, their molecular nature is still elusive (Bachhawat et al., 2013)
It acts as a dual-acting agent, combining the properties of a uricosuric and a nonsteroidal anti-inflammatory drug (NSAID)
In parallel, Per2-luciferase rhythms were monitored in synchronized cells cultured in DMEM containing 0.1 mM luciferin using a LumiCycle apparatus (Actimetrics)